In March 2025, the company announced new strategies for the immediate-to-purchaser providing of its Wegovy weight loss drug. The company proven a new pharmacy, known as NovoCare, which would charge consumers $499 per 30 days for entry to the drug, below fifty percent the price of the drug by means of other pharmaceutical distribution networks.[fift